First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Reaches New 1-Year High – Still a Buy?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBTGet Free Report) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 1,610.10 ($21.03) and last traded at GBX 1,610.10 ($21.03), with a volume of 6 shares trading hands. The stock had previously closed at GBX 1,600.37 ($20.90).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Price Performance

The company has a 50 day simple moving average of GBX 1,577.12 and a 200-day simple moving average of GBX 1,509.11. The stock has a market cap of £4.78 billion and a price-to-earnings ratio of -1,471.55. The company has a quick ratio of 9.27, a current ratio of 9.42 and a debt-to-equity ratio of 0.04.

About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation

(Get Free Report)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.

Featured Stories

Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.